Delisting riskPopularity #4,827
Biomerica (BMRA)
Makes rapid diagnostic tests and GI-focused laboratory assays for clinical and consumer use.
$2.59
vs last close−0.19 (−6.83%)
Something off on this page? Send us feedback.
Next report
Oct 21, 26
estimated · in 28 days
EPS estimate
−$1.20
Revenue estimate
$3.6M
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Jan '25Apr '25Sep '25Oct '25Jan '26Apr '26Aug '26Oct '26
Reported−$0.48−$0.48−$0.16$0.00−$0.45−$0.44−$0.38Pending
Estimate$0.32$0.16$0.32——−$1.20−$1.20−$1.20
Surprise−250.0%−400.0%−150.0%——+63.3%+68.3%—
RevenueReportedEstimate
Jan '25Apr '25Sep '25Oct '25Jan '26Apr '26Aug '26Oct '26
Reported$1.6M$1.1M$749.0K$1.4M$1.2M$987.0K$875.0KPending
Estimate$3.1M$3.0M$3.1M——$3.6M$3.6M$3.6M
Surprise−47.2%−62.7%−75.8%——−72.8%−75.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2028 | $0.32 | — | — |
| Aug 2028 | $0.16 | — | — |
| May 2028 | $0.16 | — | — |
| Feb 2028 | −$0.16 | — | — |
| Nov 2027 | −$0.96 | — | — |
| Aug 2027 | −$0.80 | — | — |
| May 2027 | −$0.64 | — | — |
| Feb 2027 | −$0.96 | — | — |
| Nov 2026 | −$0.88 | — | — |
| Aug 2026 | −$1.20 | −$0.38 | +68.3% |
| Oct 2026 | −$1.20 | — | — |
| Apr 2026 | −$1.20 | −$0.44 | +63.3% |
| Jan 2026 | — | −$0.45 | — |
| Oct 2025 | — | $0.00 | — |
| Sep 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Jan 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Jan 2022 | |||
| Oct 2021 | |||
| Aug 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Oct 2020 | |||
| Sep 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Aug 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 2028 | $0.32 | — | — | $3.1M | — | — | — |
| Aug 2028 | $0.16 | — | — | $3.0M | — | — | — |
| May 2028 | $0.16 | — | — | $2.8M | — | — | — |
| Feb 2028 | −$0.16 | — | — | $2.7M | — | — | — |
| Nov 2027 | −$0.96 | — | — | $2.1M | — | — | — |
| Aug 2027 | −$0.80 | — | — | $2.9M | — | — | — |
| May 2027 | −$0.64 | — | — | $1.8M | — | — | — |
| Feb 2027 | −$0.96 | — | — | $1.9M | — | — | — |
| Nov 2026 | −$0.88 | — | — | $2.2M | — | — | — |
| Aug 31, 2026 | −$1.20 | −$0.38 | +68.3% | $3.6M | $875.0K | −75.9% | −2.3% |
| Oct 21, 2026 | −$1.20 | — | — | $3.6M | — | — | — |
| Apr 13, 2026 | −$1.20 | −$0.44 | +63.3% | $3.6M | $987.0K | −72.8% | +1.0% |
| Jan 14, 2026 | — | −$0.45 | — | — | $1.2M | — | −0.7% |
| Oct 14, 2025 | — | $0.00 | — | — | $1.4M | — | −0.7% |
| Sep 1, 2025 | |||||||
| Apr 14, 2025 | |||||||
| Jan 15, 2025 | |||||||
| Oct 15, 2024 | |||||||
| Aug 28, 2024 | |||||||
| Apr 12, 2024 | |||||||
| Jan 16, 2024 | |||||||
| Oct 12, 2023 | |||||||
| Aug 25, 2023 | |||||||
| Apr 14, 2023 | |||||||
| Jan 13, 2023 | |||||||
| Oct 13, 2022 | |||||||
| Aug 29, 2022 | |||||||
| Apr 14, 2022 | |||||||
| Jan 12, 2022 | |||||||
| Oct 14, 2021 | |||||||
| Aug 27, 2021 | |||||||
| Apr 14, 2021 | |||||||
| Jan 14, 2021 | |||||||
| Oct 15, 2020 | |||||||
| Sep 1, 2020 | |||||||
| Apr 14, 2020 | |||||||
| Jan 15, 2020 | |||||||
| Oct 16, 2019 | |||||||
| Aug 30, 2019 | |||||||
| Apr 15, 2019 | |||||||
| Jan 15, 2019 | |||||||
| Oct 16, 2018 | |||||||
| Aug 30, 2018 | |||||||
| Apr 16, 2018 | |||||||
| Jan 16, 2018 | |||||||
| Oct 16, 2017 | |||||||
| Aug 30, 2017 | |||||||
| Apr 14, 2017 | |||||||
| Jan 17, 2017 | |||||||
| Oct 17, 2016 | |||||||
| Aug 30, 2016 | |||||||
| Apr 14, 2016 | |||||||
| Jan 14, 2016 | |||||||
| Oct 15, 2015 | |||||||
| Sep 1, 2015 |